Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04468061
Title Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stamford Hospital RECRUITING Stamford Connecticut 06904 United States Details
University of Chicago Medical Center RECRUITING Chicago Illinois 60637 United States Details
Eastern Maine Medical Center RECRUITING Brewer Maine 04412 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
DFCI @ Foxborough RECRUITING Foxborough Massachusetts 02035 United States Details
DFCI @ Milford Regional Hospital RECRUITING Milford Massachusetts 01757 United States Details
DF/BWCC in Clinical Affiliation with South Shore Hospital RECRUITING South Weymouth Massachusetts 02190 United States Details
The University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27599 United States Details
University of Pennsylvania-Abramson Cancer Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute RECRUITING Chattanooga Tennessee 37404 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field